Physician profile
Anthony Dempsey
NPI 1417120072
$6,621.82
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $692 · 2023: $4,603 · 2024: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,340 · Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,340.00 |
| Food and Beverage | $589.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $5,936.28 | 2022-2024 | Vidas Nephrocheck, Nephrocheck Liquid Control Kit |
| Medtronic, INC. | $233.90 | 2022-2023 | Endurant Iis, Corevalve Evolut R |
| La Jolla Pharmaceutical Company | $126.70 | 2024 | Giapreza |
| Astrazeneca Pharmaceuticals LP | $102.72 | 2022 | |
| Corcym INC | $102.12 | 2023 | Perceval |
| Medline Industries LP | $40.75 | 2023 | |
| W. L. Gore & Associates, INC. | $36.98 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Edwards Lifesciences Corporation | $22.85 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.52 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Dempsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.